Literature DB >> 20539079

Optimizing HIV treatment programs.

Sergio Bautista-Arredondo1, Tyler E Martz, Veronika J Wirtz, Stefano M Bertozzi.   

Abstract

PURPOSE OF REVIEW: Increasing demand for HIV treatment and limited resource availability will require the optimization of treatment programming to not only improve individual treatment outcomes, but also to maximize overall benefit for available resources. RECENT
FINDINGS: Available research, although recognizing the importance of ensuring or improving treatment adherence, largely focuses on patient barriers or incentives. More research is necessary to examine how decisions made at all levels of treatment programming affect treatment outcomes.
SUMMARY: Explicit decisions regarding treatment access, initiation, drug combinations, and potential termination of treatment along with addressing incentives and barriers to treatment adherence are necessary to maximize the overall benefit for available resources. This factor will depend on the involvement of the three main treatment actors, program managers, health practitioners, and patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20539079     DOI: 10.1097/COH.0b013e32833860d3

Source DB:  PubMed          Journal:  Curr Opin HIV AIDS        ISSN: 1746-630X            Impact factor:   4.283


  2 in total

1.  Assessing cost and technical efficiency of HIV prevention interventions in sub-Saharan Africa: the ORPHEA study design and methods.

Authors:  Sergio Bautista-Arredondo; Sandra G Sosa-Rubí; Marjorie Opuni; Ada Kwan; Claire Chaumont; Jenny Coetzee; Jeanine Condo; Kumbutso Dzekedzeke; Omar Galárraga; Neil Martinson; Felix Masiye; Sabin Nsanzimana; Richard Wamai; Joseph Wang'ombe
Journal:  BMC Health Serv Res       Date:  2014-11-29       Impact factor: 2.655

2.  Voluntary Medical Male Circumcision for HIV Prevention in Malawi: Modeling the Impact and Cost of Focusing the Program by Client Age and Geography.

Authors:  Katharine Kripke; Frank Chimbwandira; Zebedee Mwandi; Faustin Matchere; Melissa Schnure; Jason Reed; Delivette Castor; Sema Sgaier; Emmanuel Njeuhmeli
Journal:  PLoS One       Date:  2016-07-13       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.